• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对 LGBTQ+ 群体中人类乳头瘤病毒与癌症预防的数字叙事干预组件:形成性混合方法探究

Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry.

作者信息

Darville-Sanders Gabrielle, Munroe Dominique, Corluyan Emilie, Ikoiwak Utibeabasi, Nguyen Jennifer, Mandula Chad, Thomas Portia, Sanders Brandon

机构信息

Department of Public Health, Mercer University, 3001 Mercer University Drive, Atlanta, GA, 30341, United States, 1 678-547-6492.

College of Pharmacy, Mercer University, Atlanta, GA, United States.

出版信息

JMIR Form Res. 2025 May 30;9:e58163. doi: 10.2196/58163.

DOI:10.2196/58163
PMID:40446324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12143858/
Abstract

BACKGROUND

Human papillomavirus (HPV) is one of the most prevalent sexually transmitted infections in the United States; however, vaccination uptake falls far below the goal of 80% of the population set forth by Healthy People 2030. Specifically, within the LGBTQ+ (lesbian, gay, bisexual, transgender, queer/questioning) population, HPV vaccination adherence remains a complex issue. Due to the widespread use of technology within the young adult population, digital health tools such as digital storytelling (DST) have been promoted as an effective way to increase vaccination uptake.

OBJECTIVE

The purpose of this study was to conduct a formative inquiry into (1) what components should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations and (2) what dissemination channels would be more effective and impact the uptake and completion of the HPV vaccine among sexual and gender minority populations. Additionally, this study aims to provide insight into perceived HPV risk and its implications on the HPV vaccine uptake within the LGBTQ+ population.

METHODS

A mixed methods study was conducted between January 2021 and September 2021 in Atlanta, Georgia. Intake surveys were distributed to individuals identifying as members of the LGBTQ+ community to examine demographic characteristics, barriers to vaccine adherence, and current HPV vaccination status. Perceived HPV risk was assessed using 5 statements on a 1 to 7 Likert scale. Key informant interviews were conducted via Zoom with participants who completed the intake surveys and consented to be interviewed. Transcripts were coded and analyzed using the constant comparison method for emergent themes surrounding components of effective DST campaigns.

RESULTS

Forty-seven individuals completed the intake survey and interview. A total of 13 out of 47 (27.7%) of participants indicated that they were not sure when provided with the statement "I am likely to get HPV", whereas 12 out of 47 (29.8%) participants strongly disagreed with the statement "I am at high risk for getting HPV" and 13 out of 47 (27.7%) participants indicated that they were not sure when presented with the statement "HPV would be a serious threat to the quality of my life." A total of 14 out of 47 (29.8%) participants responded that they were not sure to the statement "HPV would be a severe threat to my health" and 13 out of 47 (27.7%) participants strongly agreed that "HPV would be a severe threat to my sex life." Qualitative analysis indicated a high level of stigma experienced in interactions between the LGBTQ+ population and private practitioners. Major barriers to vaccination hesitancy were concerns about age, perceived reduced risk, and lack of provider recommendation. Participant interviews revealed that "Real Outcomes," and "Accurate Representation" were the main components that should be considered for inclusion in an HPV documentary tailored for sexual and gender minority populations.

CONCLUSIONS

Creation of a DST intervention within the LGBTQ+ population should include information surrounding the real outcomes of HPV and accurate representation.

摘要

背景

人乳头瘤病毒(HPV)是美国最常见的性传播感染之一;然而,疫苗接种率远低于《健康人民2030》设定的80%的人口目标。具体而言,在 LGBTQ+(女同性恋、男同性恋、双性恋、跨性别者、酷儿/疑问者)群体中,HPV疫苗接种依从性仍然是一个复杂的问题。由于技术在年轻人群体中的广泛应用,数字健康工具如数字叙事(DST)已被推广为提高疫苗接种率的有效方式。

目的

本研究的目的是进行一项形成性调查,以探究(1)为性少数群体和性别少数群体量身定制的HPV纪录片应纳入哪些要素,以及(2)哪些传播渠道会更有效,并影响性少数群体和性别少数群体对HPV疫苗的接种和完成情况。此外,本研究旨在深入了解对HPV风险的认知及其对LGBTQ+群体中HPV疫苗接种的影响。

方法

2021年1月至2021年9月在佐治亚州亚特兰大进行了一项混合方法研究。向自认为是LGBTQ+社区成员的个体发放了入组调查问卷,以调查人口统计学特征、疫苗接种依从性障碍和当前HPV疫苗接种状况。使用1至7李克特量表上的5条陈述来评估对HPV风险的认知。通过Zoom对完成入组调查问卷并同意接受访谈的参与者进行了关键信息访谈。使用持续比较法对有效DST活动要素的相关新出现主题的访谈记录进行编码和分析。

结果

47人完成了入组调查和访谈。在47名参与者中,共有13人(27.7%)在被问及“我可能会感染HPV”时表示不确定,而47名参与者中有12人(29.8%)强烈不同意“我感染HPV的风险很高”这一陈述,47名参与者中有13人(27.7%)在被问及“HPV会对我的生活质量构成严重威胁”时表示不确定。在47名参与者中,共有14人(29.8%)对“HPV会对我的健康构成严重威胁”这一陈述回答不确定,47名参与者中有13人(27.7%)强烈同意“HPV会对我的性生活构成严重威胁”。定性分析表明,LGBTQ+群体与私人执业者互动时存在高度的污名化现象。疫苗接种犹豫的主要障碍是对年龄的担忧、感知到的风险降低以及缺乏医疗服务提供者的推荐。参与者访谈显示,“真实结果”和“准确呈现”是为性少数群体和性别少数群体量身定制的HPV纪录片应考虑纳入的主要要素。

结论

在LGBTQ+群体中开展DST干预应包括有关HPV真实结果的信息和准确呈现。

相似文献

1
Components of a Digital Storytelling Intervention for Human Papillomavirus and Cancer Prevention Among LGBTQ+ Individuals: Formative Mixed Methods Inquiry.针对 LGBTQ+ 群体中人类乳头瘤病毒与癌症预防的数字叙事干预组件:形成性混合方法探究
JMIR Form Res. 2025 May 30;9:e58163. doi: 10.2196/58163.
2
Recruitment of Young Gay, Bisexual, and Other Men Who Have Sex With Men for a Web-Based Human Papillomavirus Vaccination Intervention: Differences in Participant Characteristics and Study Engagement by Recruitment Source in a Randomized Controlled Trial.招募年轻男同性恋者、双性恋者及其他与男性发生性行为的男性参与基于网络的人乳头瘤病毒疫苗接种干预研究:随机对照试验中按招募来源划分的参与者特征及研究参与度差异
J Med Internet Res. 2025 Jan 3;27:e64668. doi: 10.2196/64668.
3
Knowledge Levels and Health Beliefs of Lesbian, Gay, Bisexual, Transgender, and Queer Population About Human Papilloma Virus and Vaccine.女同性恋、男同性恋、双性恋、跨性别者及酷儿群体关于人乳头瘤病毒和疫苗的知识水平与健康观念
Public Health Nurs. 2025 Mar-Apr;42(2):665-674. doi: 10.1111/phn.13492. Epub 2024 Nov 27.
4
A Qualitative Analysis of Young Sexual Minority Men's Perspectives on Human Papillomavirus Vaccination.年轻的性少数男性对人乳头瘤病毒疫苗接种的看法的定性分析。
LGBT Health. 2019 Oct;6(7):350-356. doi: 10.1089/lgbt.2019.0086. Epub 2019 Sep 26.
5
Perceptions of HPV and attitudes towards HPV vaccination amongst men who have sex with men: A qualitative analysis.男男性行为者对人乳头瘤病毒(HPV)的认知及对HPV疫苗接种的态度:一项定性分析
Br J Health Psychol. 2017 May;22(2):345-361. doi: 10.1111/bjhp.12233. Epub 2017 Feb 13.
6
Facilitators and barriers of HPV vaccination: a qualitative study in rural Georgia.人乳头瘤病毒(HPV)疫苗接种的促进因素和障碍:佐治亚州农村的一项定性研究。
BMC Cancer. 2024 May 15;24(1):592. doi: 10.1186/s12885-024-12351-1.
7
Associations Between Risk Perception and HPV Knowledge and Vaccine Uptake: Highlighting the LGBTQ+ Population.风险认知与HPV知识及疫苗接种率之间的关联:聚焦LGBTQ+群体
Otolaryngol Head Neck Surg. 2024 Jun;170(6):1684-1695. doi: 10.1002/ohn.664. Epub 2024 Feb 8.
8
Facilitators of and barriers to HPV vaccination among sexual and gender minority patients at a Boston community health center.在波士顿社区健康中心,性少数和性别少数患者 HPV 疫苗接种的促进因素和障碍。
Vaccine. 2018 Jun 18;36(26):3868-3875. doi: 10.1016/j.vaccine.2018.02.043. Epub 2018 May 16.
9
Vaccination uptake in LGBTQ adults in two US states: Findings from the QVax study.美国两个州LGBTQ成年人群体的疫苗接种情况:QVax研究结果
Vaccine. 2024 Dec 2;42(26):126320. doi: 10.1016/j.vaccine.2024.126320. Epub 2024 Sep 14.
10
The Impact of a Human Papillomavirus Facebook-Based Intervention (#HPVVaxTalks) Among Young Black (African American and Sub-Saharan African Immigrants) Adults: Pilot Pre- and Poststudy.基于脸书的人乳头瘤病毒干预措施(#HPVVaxTalks)对年轻黑人(非裔美国人和撒哈拉以南非洲移民)成年人的影响:预研究和后研究试点
JMIR Form Res. 2025 Apr 2;9:e69609. doi: 10.2196/69609.

本文引用的文献

1
Understanding Low Vaccine Uptake in the Context of Public Health in High-Income Countries: A Scoping Review.高收入国家公共卫生背景下疫苗接种率低的原因:一项范围综述
Vaccines (Basel). 2024 Mar 4;12(3):269. doi: 10.3390/vaccines12030269.
2
HPV Vaccination Adherence in Working-Age Men: A Systematic Review and Meta-Analysis.工作年龄男性对人乳头瘤病毒疫苗的接种依从性:一项系统评价与荟萃分析
Vaccines (Basel). 2023 Feb 15;11(2):443. doi: 10.3390/vaccines11020443.
3
Influenza Vaccine Hesitancy: Scope, Influencing Factors, and Strategic Interventions.流感疫苗犹豫:范围、影响因素和策略干预。
Pediatr Clin North Am. 2023 Apr;70(2):227-241. doi: 10.1016/j.pcl.2022.11.003.
4
Tough Talks COVID-19 Digital Health Intervention for Vaccine Hesitancy Among Black Young Adults: Protocol for a Hybrid Type 1 Effectiveness Implementation Randomized Controlled Trial.针对黑人青年成年人疫苗犹豫问题的“艰难对话”COVID-19数字健康干预措施:1型混合有效性实施随机对照试验方案
JMIR Res Protoc. 2023 Feb 13;12:e41240. doi: 10.2196/41240.
5
Diné teachings and public health students informing peers and relatives about vaccine education: Providing Diné (Navajo)-centered COVID-19 education materials using student health messengers.达内族教义和公共卫生学生向同龄人及亲属宣传疫苗知识:利用学生健康信使提供以达内族(纳瓦霍族)为中心的 COVID-19 教育材料。
Front Public Health. 2022 Dec 14;10:1046634. doi: 10.3389/fpubh.2022.1046634. eCollection 2022.
6
Vaccine Hesitancy: Contemporary Issues and Historical Background.疫苗犹豫:当代问题与历史背景
Vaccines (Basel). 2022 Sep 22;10(10):1595. doi: 10.3390/vaccines10101595.
7
Adherence to the Recommended HPV Vaccine Dosing Schedule among Adolescents Aged 13 to 17 Years: Findings from the National Immunization Survey-Teen, 2019-2020.13至17岁青少年对推荐的人乳头瘤病毒(HPV)疫苗接种程序的依从性:2019 - 2020年全国青少年免疫调查结果
Vaccines (Basel). 2022 Apr 8;10(4):577. doi: 10.3390/vaccines10040577.
8
Corrigendum to: 2531. Using Peer-to-Peer Education to Increase Awareness and Uptake of HPV Vaccine Among Chinese International Students.对《2531. 利用同伴教育提高中国留学生对人乳头瘤病毒疫苗的认识和接种率》的勘误
Open Forum Infect Dis. 2022 Apr 10;9(5):ofac062. doi: 10.1093/ofid/ofac062. eCollection 2022 May.
9
A Digital Storytelling Intervention for Vietnamese American Mothers to Promote Their Children's HPV Vaccination.数字故事讲述干预措施,以提高越南裔美国母亲对子女 HPV 疫苗接种的认识。
Cancer Prev Res (Phila). 2022 Jul 5;15(7):465-472. doi: 10.1158/1940-6207.CAPR-21-0618.
10
COVID-19 Vaccine Hesitancy and How to Address It.新冠病毒疫苗犹豫及其应对措施。
Workplace Health Saf. 2022 Feb;70(2):56-62. doi: 10.1177/21650799211073525. Epub 2022 Jan 25.